Top

Published in:

01-06-2011 | Materno-fetal Medicine

The clinical management of hyperemesis gravidarum

Author: Shipra Sonkusare

Published in: Archives of Gynecology and Obstetrics | Issue 6/2011

Abstract

Hyperemesis gravidarum is a severe and disabling condition with potentially life-threatening complications. It is likely to have a multifactorial etiology which contributes to the difficulty in treatment. Treatment is supportive with correction of dehydration and electrolyte disturbance, antiemetic therapy, prevention and treatment of complications like Wernicke’s encephalopathy, osmotic demyelination syndrome, thromboembolism, and good psychological support. There are abundant data on the safety of antihistamines, phenothiazines, and metoclopromide in early pregnancy and treatment should therefore not be withheld on the basis of teratogenicity concerns. Thiamine replacement is indicated in hyperemesis gravidarum to prevent development of Wernicke’s encephalopathy.

Kallen B (1987) Hyperemesis during pregnancy and delivery outcome: a registry study. Eur J Obstet Reprod Bio 26:292–302

Goodwin TM (2004) Nausea and vomiting of pregnancy. ACOG Practice Bulletin 52. American College of Obstetricians and Gynecologists. Obstet Gynecol 103:803–815

King TL, Murphy PA (2009) Evidence-based approaches to managing nausea and vomiting in early pregnancy. J Midwifery Women Health 54(6):430–444CrossRef

Sherman PW, Flaxman SM (2002) Nausea and vomiting of pregnancy in evolutionary perspective. Am J Obstet Gynecol 186:S190–S197PubMedCrossRef

Trogstad LI, Stoltenberg C, Magnus P et al (2005) Recurrence risk in hyperemesis gravidarum. BJOG 112:1641–1645PubMedCrossRef

Rochelson B, Vohra N, Darvishzadeh J et al (2003) Low prepregnancy ideal weight: height ratio in women with hyperemesis gravidarum. J Reprod Med 48:422–424PubMed

Fell DB, Dodds L, Joseph KS et al (2006) Risk factors for hyperemesis gravidarum requiring hospital admission during pregnancy. Obstet Gynecol 107:277–284PubMedCrossRef

Kallen B, Lundberg G, Aberg A (2003) Relationship between vitamin use, smoking, and nausea and vomiting of pregnancy. Acta Obstet Gynecol Scand 82:916–920PubMed

Tsuruta E, Tada H, Tamaki H et al (1995) Pathogenic role of asialo human chorionic gonadotropin in gestational thyrotoxicosis. J Clin Endocrinol Metab 80(2):350–355PubMedCrossRef

10.

Lagiou P, Tamini R, Mucci LA et al (2003) Nausea and vomiting in pregnancy in relation to prolactin, estrogens, and progesterone: a prospective study. Obstet Gynecol 101:639–644PubMedCrossRef

11.

Munch S (2002) Chicken or the egg? The biological-psychological controversy surrounding hyperemesis gravidarum. Soc Sci Med 55(7):1267–1278PubMedCrossRef

12.

Swallow B, Lindow S, Masson E et al (2004) Psychological health in early pregnancy: relationship with nausea and vomiting. J Obstet Gynaecol 24(1):28–32PubMedCrossRef

13.

Sandven I, Abdelnoor M, Nesheim B et al (2009) Helicobacter pylori infection and hyperemesis gravidarum: a systematic review and meta-analysis of case-control studies. Acta Obstet Gynecol Scand 88(11):1190–1200PubMedCrossRef

14.

Karaca C, Guler N, Yazar A et al (2004) Is lower socio-economic status a risk factor for Helicobacter pylori infection in pregnant women with hyperemesis gravidarum? Turk J Gastroenterol 15:86–89PubMed

15.

Yumi S, Akihiko S, Antonio F et al (2003) Relationship between severity of hyperemesis gravidarum and fetal DNA concentration in maternal plasma. Clin Chem 49:1667–1669CrossRef

16.

Sekizawa A, Jimbo M, Saito H et al (2003) Cell-free fetal DNA in the plasma of pregnant women with severe fetal growth restriction. Am J Obstet Gynecol 188:480–484PubMedCrossRef

17.

Sekizawa A, Yokokawa K, Sugito Y et al (2003) Evaluation of bi-directional transfer of plasma DNA through placenta. Hum Genet 113:307–310PubMedCrossRef

18.

Minagawa M, Narita J, Tada T et al (1999) Mechanisms underlying immunologic states during pregnancy: possible association of the sympathetic nervous system. Cell Immune 196:1–13CrossRef

19.

Kaplan PB, Gucer F, Sayin NC et al (2003) Maternal serum cytokine levels in women with hyperemesis gravidarum in the first trimester of pregnancy. Fertil Steril 79:498–502PubMedCrossRef

20.

Kuscu NK, Yildirim Y, Koyuncu F et al (2003) Interleukin–6 levels in hyperemesis gravidarum. Arch Gynecol Obstet 269:13–15PubMedCrossRef

21.

Koren G, Boskovic R, Hard M et al (2002) Motherisk-PUQE (pregnancy-unique quantification of emesis and nausea) scoring system for nausea and vomiting of pregnancy. Am J Obstet Gynecol 186(5 Suppl Understanding):S228–S231PubMedCrossRef

22.

Koren G, Piwko C, Ahn E et al (2005) Validation studies of the Pregnancy Unique-Quantification of Emesis (PUQE) scores. J Obstet Gynaecol 25(3):241–244PubMedCrossRef

23.

Lacasse A, Rey E, Ferreira E et al (2008) Validity of a modified Pregnancy-Unique Quantification of Emesis and Nausea (PUQE) scoring index to assess severity of nausea and vomiting of pregnancy. Am J Obstet Gynecol 198(1):71 e1–e7

24.

Leylek OA, Toyaksi M, Erselcan T et al (1999) Immunologic and biochemical factors in hyperemesis gravidarum with or without hyperthyroxinemia. Gynecol Obstet Invest 47:229–234PubMedCrossRef

25.

Chiossi G, Neri I, Cavazzuti M et al (2006) Hyperemesis gravidarum complicated by Wernicke encephalopathy: background, case report, and review of the literature. Obstet Gynecol Surv 61(4):255–268PubMedCrossRef

26.

Basso O, Olsen J (2001) Sex ratio and twinning in women with hyperemesis or pre-Eclampsia. Epidemiology 12(6):747–749PubMedCrossRef

27.

Felemban A, Bakri Y, Alkharif H et al (1998) Complete molar pregnancy: clinical trends at King Fahad Hospital, Riyadh, Kingdom of Saudi Arabia. J Reprod Med 43:11–13PubMed

28.

Kirk E, Papageorghiou A, Condous G et al (2006) Hyperemesis gravidarum: is an ultrasound scan necessary? Hum Reprod 21(9):2440–2442PubMedCrossRef

29.

Bashiri A, Neumann L, Maymon E et al (1995) Hyperemesis gravidarum: epidemiologic features, complications and outcome. Eur J Obstet Gynecol Reprod Biol 63(2):135–138PubMedCrossRef

30.

Depue R, Bernstein L, Ross R et al (1987) Hyperemesis gravidarum in relation to estradiol levels, pregnancy outcome, and other maternal factors: a seroepidemiologic study. Am J Obstet Gynecol 156:1137–1141PubMed

31.

Gross S, Librach C, Cocutti A (1989) Maternal nutritional effects and severe hyperemesis gravidarum: a predictor of fetal outcome. Am J Obstet Gynecol 160(4):906–909PubMed

32.

Moore R (1999) Diabetes in pregnancy. In: Creasy RK, Resnik R (eds) Maternal-fetal medicine, 4th edn. W.B. Saunders, Philadelphia, p 964

33.

Van Stuijevenberg E, Schabort I, Labadarios D et al (1995) The nutritional status and treatment of patients with hyperemesis gravidarum. Am J Obstet Gynecol 172:1585–1591CrossRef

34.

Selitsky T, Chandra P, Shiavello HJ (2006) Wernicke’s encephalopathy with hyperemesis and ketoacidosis. Obstet Gynecol 107(2 Pt 2):486–490PubMedCrossRef

35.

Spruill C, Kuller A (2002) Hyperemesis gravidarum complicated by Wernicke’s encephalopathy. Obstet Gynecol 99(5):875–877PubMedCrossRef

36.

Albaar M, Adam J (2004) Gestational transient thyrotoxicosis. Acta Med Indones 41(2):99–104

37.

Hershman J (2004) Physiological and pathological aspects of the effect of human chorionic gonadotropin on the thyroid. Best Pract Res Clin Endocrinol Metab 18(2):249–265PubMedCrossRef

38.

Fagan A (1999) Diseases of the liver, biliary system, and pancreas. In: Creasy R (ed) Maternal-fetal medicine, 4th edn. W.B. Saunders, Philadelphia, p 1056

39.

Robertson C, Millar H (1999) Hyperamylasemia in bulimia nervosa and hyperemesis gravidarum. Int J Eat Disord 26(2):223–227PubMedCrossRef

40.

Deuchar N (1995) Nausea and vomiting in pregnancy: a review of the problem with particular regard to psychological and social aspects. BrJ Obstet Gynaecol 102:6–8CrossRef

41.

Buckwalter G, Simpson S (2002) Psychological factors in the etiology and treatment of severe nausea and vomiting in pregnancy. Am J Obstet Gynecol 186(5 Suppl. Understanding):S210–S214PubMedCrossRef

42.

Power Z, Campbell M, Kilcoyne P et al (2010) The Hyperemesis Impact of Symptoms Questionnaire: development and validation of a clinical tool. Int J Nurs Stud 47(1):67–77PubMedCrossRef

43.

Alalade O, Khan R, Dawlatly B (2007) Day-case management of hyperemesis gravidarum: feasibility and clinical efficacy. J Obstet Gynaecol 27(4):363–364PubMedCrossRef

44.

Naef R, Chauhan S, Roach H et al (1995) Treatment for hyperemesis gravidarum in the home: an alternative to hospitalization. J Perinatol 15(4):289–292PubMed

45.

Jennings-Sanders A (2009) A case study approach to Hyperemesis Gravidarum: home care implications. Home Healthc Nurse 27(6):347–351PubMedCrossRef

46.

Buttino L Jr, Coleman S, Bergauer N et al (2000) Home subcutaneous metoclopramide therapy for hyperemesis gravidarum. J Perinatol 20(6):359–362PubMedCrossRef

47.

Bottomley C, Bourne T (2009) Management strategies for hyperemesis. Best Prac Res Clin Obstet Gynaecol 23:549–564CrossRef

48.

McKeigue M, Lamm H, Linn S et al (1994) Bendectin and birth defects: I. A meta-analysis of the epidemiologic studies. Teratology 50:27–37PubMedCrossRef

49.

Quinlan D, Hill A (2003) Nausea and vomiting of pregnancy. Am Fam Physician 8(1):121–128

50.

Gill S, Einarson A (2007) The safety of drugs for the treatment of nausea and vomiting of pregnancy. Expert Opin Drug Saf 6(6):685–694PubMedCrossRef

51.

Seto A, Einarson T, Koren G (1997) Pregnancy outcome following first trimester exposure to antihistamines: meta-analysis. Am J Perinatol 14(3):119–124PubMedCrossRef

52.

Lacasse A, Lagoutte A, Ferreira E et al (2009) Metoclopramide and diphenhydramine in the treatment of hyperemesis gravidarum: effectiveness and predictors of rehospitalisation. Eur J Obstet Gynecol Reprod Biol 143(1):43–49PubMedCrossRef

53.

Goodwin T, Poursharif B, Korst L et al (2008) Secular trends in the treatment of hyperemesis gravidarum. Am J Perinatol 25(3):141–147PubMedCrossRef

54.

Ilan M, Rafael G, Gideon K et al (2009) The safety of metoclopramide use in the first trimester of pregnancy. N Engl J Med 360:2528–2535CrossRef

55.

Layton D, Wilton L, Shakir S (2009) Examining the tolerability of the non-sedating antihistamine desloratadine: a prescription-event monitoring study in England. Drug Saf 32(2):169–179PubMedCrossRef

56.

Weber-Schoendorfer C, Schaefer C (2008) The safety of cetrizine during pregnancy: A prospective observational cohort study. Reprod Toxicol 26(1):19–23PubMedCrossRef

57.

Asker C, Norstedt Wikner B, Källén B (2005) Use of antiemetic drugs during pregnancy in Sweden. Eur J Clin Pharmacol 61(12):899–906PubMedCrossRef

58.

Sahakian V, Rouse D, Sipes S et al (1991) Vitamin B6 is effective therapy for nausea and vomiting of pregnancy: a randomized, double-blind placebo-controlled study. Obstet Gynecol 78(1):33–36PubMed

59.

Vutyavanich T, Wongtra-ngan S, Ruangsri R (1995) Pyridoxine for nausea and vomiting of pregnancy: a randomized, double-blind, placebo-controlled trial. Am J Obstet Gynecol 173(3):881–884PubMedCrossRef

60.

Heazell A, Langford N, Judge J et al (2005) The use of levomepromazine in hyperemesis gravidarum resistant to drug therapy—a case series. Reprod Toxicol 20(4):569–572PubMedCrossRef

61.

Einarson A, Boskovic R (2009) Use and safety of antipsychotic drugs during pregnancy. J Psychiatr Pract 15(3):183–192PubMedCrossRef

62.

Safari H, Fassett M, Souter I et al (1998) The efficacy of methylprednisolone in the treatment of hyperemesis gravidarum: a randomized, double-blind, controlled study. Am J Obstet Gynecol 179(4):921–924PubMedCrossRef

63.

Ziaei S, Hosseiney F, Faghihzadeh S (2004) The efficacy low dose of prednisolone in the treatment of hyperemesis gravidarum. Acta Obstet Gynecol Scand 83(3):272–275PubMed

64.

Nelson-Piercy C, Fayers P, De Swiet M (2001) Randomised, double-blind, placebo-controlled trial of corticosteroids for the treatment of hyperemesis gravidarum. BJOG 108(1):9–15PubMedCrossRef

65.

Bondok R, El Sharnouby N, Eid H et al (2006) Pulsed steroid therapy is an effective treatment for intractable hyperemesis gravidarum. Crit Care Med 34(11):2781–2783PubMedCrossRef

66.

Fraser F, Sajoo A (1995) Teratogenic potential of corticosteroids in humans. Teratology 51:45–46PubMedCrossRef

67.

Mahady B, Pendland L, Yun S et al (2003) Ginger (Zingiber officinale Roscoe) and the gingerols inhibit the growth of Cag A+ strains of Helicobacter pylori. Anticancer Res 23:3699–3702PubMed

68.

Borrelli F, Capasso R, Aviello G et al (2005) Effectiveness and safety of ginger in the treatment of pregnancy-induced nausea and vomiting. Obstet Gynecol 105(4):849–856PubMedCrossRef

69.

Fischer-Rasmussen W, Kjaer S, Dahl C et al (1991) Ginger treatment of hyperemesis gravidarum. Eur J Obstet Gynecol Reprod Biol 38(1):19–24PubMedCrossRef

70.

Vutyavanich T, Kraisarin T, Ruangsri R (2001) Ginger for nausea and vomiting in pregnancy: randomized, double-masked, placebo-controlled trial. Obstet Gynecol 97(4):577–582PubMedCrossRef

71.

Willetts K, Ekangaki A, Eden J (2003) Effect of a ginger extract on pregnancy-induced nausea: a randomised controlled trial. Aust N Z J Obstet Gynaecol 43(2):139–144PubMedCrossRef

72.

Smith C, Crowther C, Willson K et al (2004) A randomized controlled trial of ginger to treat nausea and vomiting in pregnancy. Obstet Gynecol 103(4):639–645PubMedCrossRef

73.

Portnoi G, Chng LA, Karimi-Tabesh L et al (2003) Prospective comparative study of the safety and effectiveness of ginger for the treatment of nausea and vomiting in pregnancy. Am J Obstet Gynecol 189:1374–1377PubMedCrossRef

74.

Jewell D, Young G (2003) Interventions for nausea and vomiting in early pregnancy. The Cochrane Database of Systematic Reviews Issue 4 Art No CD000145. doi:10.1002/14651858.CD000145

75.

Levicheck Z, Atanackovitc G, Oepkes D et al (2002) Nausea and vomiting of pregnancy. Evidence-based treatment algorithm. Can Fam Physician 48:267–277

76.

Sahakian V, Rouse D, Siepes S et al (1991) Vitamin B6 is effective therapy for nausea and vomiting in pregnancy a randomized, double-blind placebo control study. Obstet Ginecol 78:33–36

77.

Hsu J, Clark-Glena R, Nelson D et al (1991) Nasogastric enteral feeding in the management of hyperemesis gravidarum. Obstet Gynecol 88(3):343–346CrossRef

78.

Boyce RA (1992) Enteral nutrition in hyperemesis gravidarum: a new development. J Am Diet Assoc 92(6):733–736PubMed

79.

Gulley RM, Pleog NV (1993) Gulley J (1993) Treatment of hyperemesis gravidarum with nasogastric feeding. Nutr Clin Pract 8:33–35PubMedCrossRef

80.

Barclay BA (1990) Experience with enteral nutrition in the treatment of hyperemesis gravidarum. Nutr Clin Pract 5:153–155PubMedCrossRef

81.

Ogura JM, Francois KG, Perlow JH et al (2003) Complications associated with peripherally inserted central catheter use during pregnancy. Am J Obstet Gynecol 188:1223–1225PubMedCrossRef

82.

Paranyuk Y, Levine G, Figueroa R (2006) Candida septicemia in a pregnant woman with hyperemesis receiving parenteral nutrition. Obstet Gynecol 107(2 Part 2):535–537PubMedCrossRef

83.

Holmes VA, Wallace JMW (2005) Haemostasis in normal pregnancy: a balancing act? Biochem Soc Trans 33(part 2):428–432PubMed

84.

Godil A, Chen YK (1998) Percutaneous endoscopic gastrostomy for nutrition support in pregnancy associated with hyperemesis gravidarum and anorexia nervosa. J Parenter Enteral Nutr 22:238–241CrossRef

85.

Serrano P, Velloso A, Garcia-Luna PP et al (1998) Enteral nutrition by percutaneous endoscopic gastrojejunostomy in severe hyper emesis gravidarum: a report of two cases. Clin Nutr 17:135–139PubMedCrossRef

86.

Mazzotta P, Stewart D, Atanackovic G et al (2000) Psychosocial morbidity among women with nausea and vomiting of pregnancy: prevalence and association with anti-emetic therapy. J Psychosom Obstet Gynaecol 21:129–136PubMedCrossRef

87.

Castillo R, Ray R, Yaghmai F (1989) Central pontine myelinolysis and pregnancy. Obstet Gynecol 73:459–461PubMed

88.

Bergin P, Harvey P (1992) Wernicke’s encephalopathy and central pontine myelinolysis associated with hyperemesis gravidarum. BMJ 305(6852):517–518PubMedCrossRef

89.

Lewis G (2007) The confidential enquiry into maternal and child health (CEMACH). Saving mothers’ lives: reviewing maternal deaths to make motherhood safer—2003–2005. The seventh report on confidential enquiries into maternal deaths in the United Kingdom. London: CEMACH

90.

RCOG guideline number 37 (2004) Thromboprophylaxis during pregnancy, labour and after vaginal delivery. RCOG Press, London

91.

Mazzotta P, Stewart D, Koren G et al (2001) Factors associated with elective termination of pregnancy among Canadian and American women with nausea and vomiting of pregnancy. J Psychosom Obstet Gynaecol 22(1):7–12PubMedCrossRef

92.

Andersson L, Sundström-Poromaa I, Wulff M et al (2004) Implications of antenatal depression and anxiety for obstetric outcome. Obstet Gynecol 104(3):467–476PubMedCrossRef

93.

Bailit J (2005) Hyperemesis gravidarum: epidemiologic findings from a large cohort. Am J Obstet Gynecol 193(3 Pt 1):811–814PubMedCrossRef

94.

Dodds L, Fell D, Joseph K et al (2006) Outcomes of pregnancies complicated by hyperemesis gravidarum. Obstet Gynecol 107(2 Pt 1):285–292PubMedCrossRef

95.

Tan P, Jacob R, Quek R et al (2007) Pregnancy outcome in hyperemesis gravidarum and the effect of laboratory clinical indicators of hyperemesis severity. J Obstet Gynaecol Res 33(4):457–464PubMedCrossRef

96.

Nulman I, Rovet J, Barrera M et al. (2009) Long-term neurodevelopment of children exposed to maternal nausea and vomiting of pregnancy and dilectin. J Pediatr Jul 155(1):45–50, 50 e1–2

97.

Koren G, Maltepe C (2004) Pre-emptive therapy for severe nausea and vomiting of pregnancy and hyperemesis gravidarum. J Obstet Gynaecol 24(5):530–533PubMedCrossRef

Title: The clinical management of hyperemesis gravidarum
Author: Shipra Sonkusare
Publication date: 01-06-2011
Publisher: Springer-Verlag
Published in: Archives of Gynecology and Obstetrics / Issue 6/2011
Print ISSN: 0932-0067
Electronic ISSN: 1432-0711
DOI: https://doi.org/10.1007/s00404-011-1877-y

Keynote webinar | Spotlight on medication adherence

Springer Medicine

The clinical management of hyperemesis gravidarum

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 6/2011

Second primary cancers following borderline ovarian tumors

Is genetic polymorphism of ER-α, CYP1A1, and CYP1B1 a risk factor for uterine leiomyoma?

Does acetic acid influence the non-dysplastic Pap smear?

Successful application of vacuum-assisted closure therapy for treatment of mastitis-associated chronic breast wounds

Perinatal outcomes in condyloma acuminata pregnancies

Anti-Mullerian hormone is a better marker than inhibin B, follicle stimulating hormone, estradiol or antral follicle count in predicting the outcome of in vitro fertilization